TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07693751: A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer

Sponsor: SOTIO Biotech a.s. · Phase: PHASE1/PHASE2 · Area: ONCOLOGY · Target Enrollment: 100 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$12,566,400

Rescue Site Savings

+$8,285,970

Unlock Full NCT07693751 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07693751 Rescue Dossier →